Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [NA]

View source ↗

Summary

This entry discusses donor stem cell transplantation as a treatment option for patients with hematologic cancers, metastatic kidney cancer, and aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Kidney Cancer
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Snippet

Sponsor: University of California, San Francisco | Conditions: Chronic Myeloproliferative Disorders, Kidney Cancer | NA | Status: UNKNOWN